摘要
研究认为,在恶性肿瘤中存在少部分具有“干细胞样”特性的细胞,它们具有自我更新、无限增殖及多向分化的潜能,是形成肿瘤细胞异质性和肿瘤细胞不断扩增的根源。CD133(又称Prominin-1)是一个含有5个跨膜区域的单链糖蛋白,研究表明其是多种肿瘤干细胞的表面标记。
出处
《中国医师进修杂志》
2012年第15期76-77,共2页
Chinese Journal of Postgraduates of Medicine
参考文献2
-
1LIU Qun LI Ji-guang ZHENG Xin-yu JIN Feng DONG Hui-ting.Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas[J].Chinese Medical Journal,2009(22):2763-2769. 被引量:17
-
2张惠忠,魏益平,王梅,吴澄,杨艳旗,陈炬,曹永科.肿瘤干细胞标志物CD133和内皮素转化酶对非小细胞肺癌预后的影响[J].南方医科大学学报,2007,27(5):696-699. 被引量:11
二级参考文献38
-
1Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355: 1253-1261.
-
2A1-Hajj M, Wicha MS, Benito-Hemandez A, Morrison S J, Clarke ME Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003: 100: 3983-3988.
-
3Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
-
4Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brcal breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008; 10: R10.
-
5Storci C~ Sansone P, Trere D, Tavolari S, Taffurelli M, Ceccarelli C, et al. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol 2008; 214: 25-37.
-
6Dressier GR, Douglass EC. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci U S A 1992; 89: 1179-1183.
-
7Silberstein GB, Dressier GR, Van Hom K. Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. Oncogene 2002; 21: 1009-1016.
-
8Govind AP, Thampan RV. Membrane associated estrogen receptors and related proteins: localization at the plasma membrane and the endoplasmic reticulum. Mol Cell Biochem 2003; 253: 233-240.
-
9Filardo EJ, Thomas P. GPR30: a seven-transmembrane- spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab 2005; 16: 362-367.
-
10Gastl G, Spizzo G, Obrist P, Dunser M, Mikuz G. Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 2000; 356: 1981-1982.
共引文献25
-
1安江洪,钱莘,敖绪军,赵栋国,孙建国,陈正堂.CD133在人NSCLC组织和细胞系中表达的初步研究[J].重庆医学,2008,37(9):931-932. 被引量:4
-
2李明超,曹润福.前列腺良恶性病变组织中CD24和CD133的表达及其意义[J].江西医学院学报,2009,49(4):104-106. 被引量:1
-
3LI Hui-ping,JI Jia-fu,HOU Kuan-yong,LEI Yu-tao,ZHAO Hong-mei,WANG Jing,ZHENG Jie,LIU Jian-ying,WANG Mo-pei,XIAO Yu,WANG You-fan,LU You-yong,SUN Yan.Prediction of recurrence risk in early breast cancer using human epidermal growth factor 2 and cyclin A2[J].Chinese Medical Journal,2010(4):431-437. 被引量:12
-
4李宝秀,张晓实,刘国龙.CD133在局部晚期结肠癌肿瘤细胞中的异常表达及意义[J].广东医学,2010,31(13):1678-1681. 被引量:2
-
5ZHANG Hui LIN Ying XIAO Ying WANG San-ming LIU Xiang-xia WANG Shen-ming.Stable transfection of estrogen receptor-alpha suppresses expression of cyclooxygenase-2 and vascular endothelial growth factor-C in MDA-MB-231 breast cancer cells[J].Chinese Medical Journal,2010(15):1989-1994. 被引量:4
-
6王芳(综述,杨红鹰(审校).乳腺癌干细胞的研究进展[J].中国肿瘤,2011,20(5):361-366.
-
7刘勇,路名芝.CD133与实体肿瘤预后的研究进展[J].临床与实验病理学杂志,2011,27(6):635-637. 被引量:6
-
8姜学革,李晓瑛,赵坡,吕亚莉,钟梅.三阴性乳腺癌CD133和HER-1表达及其与预后相关性的探讨[J].中华肿瘤防治杂志,2011,18(9):684-687.
-
9王瑞海.肿瘤干细胞的分离培养及生物学特性[J].中国组织工程研究与临床康复,2011,15(27):5087-5090. 被引量:7
-
10李晓瑛,吕亚莉,刘琳,赵坡.胆管细胞癌CD133表达的临床病理意义[J].中华临床医师杂志(电子版),2012,6(1).
同被引文献19
-
1Cai C,Yu JW,Wu JG,et al.CD133 promotes the invasion and metastasis of gastric cancer via epithelial-mesenchy- mal transition[J].Zhonghua Wei Chang Wai Ke Za Zhi,2013, 16(7) :662-667.
-
2Hashimoto K,Aoyagi K,Isobe T,et al.Expression of CD133 in the cytoplasm is associated with cancer progres- sion and poor prognosis in gastric cancer [J].Gastric Can- cer,2013. [Epub ahead of print].
-
3Lee HH,Seo KJ,An CH,et al.CD133 expression is corre- lated with ehemoresistanee and early recurrence of gastric eancer[J].J Surg Oncol, 2012,106(8) :999-1004.
-
4Rice TW, Blackstone EH, Rusch VW.7th edition of the A- JCC Cancer Staging Manual: esophagus and esophagogas- tric junction [J].Ann Surg Oncol,2010,17(7):1721-1724.
-
5Rappa G,Fodstad O,Lorico A.The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma [J].Stem Cells,2008,26 (12) : 3008-3017.
-
6Hermann PC,Huber SL,Herrler T,et al.Distinct popula- tions of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer cell[J].Stem Cell. 2007,1(3) : 313-323.
-
7Wakamatsu Y, Sakamoto N, Oo HZ, et al.Expression of can- cer stem cell markers ALDH1 ,CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer [J]. Pathol Int, 2012,62(2) : 112-119.
-
8Ishigami S, Ueno S,Arigami T,et al.Prognostic impact of CD133 expression in gastric carcinoma[J].Anticancer Res, 2010,30(6) :2453-2457.
-
9Chen S, Hou JH, Feng XY, et al. Clinicopathologic signifi- cance of putative stem cell marker,CD44 and CD133,in human gastric carcinoma [J],J Surg 0ncol,2013,107(8): 799-806.
-
10唐毕锋,马立业,翟羽佳,余永伟,张敏峰,刘小康.肿瘤干细胞标志物CD133在胃癌中的表达及其临床意义[J].临床肿瘤学杂志,2008,13(6):495-498. 被引量:20
二级引证文献5
-
1胡俊华,王琦,杨艳果,卢光新.MiR-203通过SNAI2的靶向作用对胃癌细胞SGC7901侵袭和凋亡的影响[J].武汉大学学报(医学版),2014,35(6):857-861. 被引量:4
-
2杜远敏,杜柏林,梁奕,林浩.^1H-MRS波谱成像与血管性非痴呆认知障碍的关系[J].武汉大学学报(医学版),2014,35(6):885-888. 被引量:3
-
3陈莎,刘永平.CD_(133) Ki-67在胃癌的表达及临床病理意义[J].基层医学论坛,2016,20(28):3988-3989.
-
4古丽尼格尔.雪合拉提,王延蛟,祖力皮喀尔.阿卜杜热合曼,娜孜拉木.玉苏甫江,斯坎德尔.白克力.食管癌患者外周血中miR-181b-5p表达水平下降[J].基础医学与临床,2018,38(5):600-603.
-
5赵新宇.探究胃癌中CD133表达的临床价值及其与缺氧诱导因子-1α表达的相关性[J].世界最新医学信息文摘,2017,17(92):172-172.
-
1赵洪,张琚,冯剑利,于自然.血清PSA水平与前列腺癌的检测[J].中华泌尿外科杂志,1998,19(10):638-640. 被引量:13
-
2李小平.肿瘤异质性及其在妇科恶性肿瘤诊疗中的思考[J].中华临床医师杂志(电子版),2010,4(3):14-17. 被引量:3
-
3周桥,杨光华,谭永淑.膀胱癌细胞异质性和浸润性的关系[J].华西医学,1992,7(1):64-66.
-
4许凤莲,李玉林,张丽红,王心蕊,邱铁东.胃肠道癌间质血管内皮细胞异质性的研究[J].中华医学杂志,1994,74(7):431-432. 被引量:1
-
5杨冰梅,陈朝伦,黄瑢瑢,郭怀荣,鲍运海,李培祥.颅内肿瘤细胞异质性的免疫组织化学研究[J].新疆医学院学报,1994,17(1):1-6. 被引量:1
-
6蒋世旭,杨光华.肺癌的细胞异质性研究[J].中华病理学杂志,1991,20(3):178-180. 被引量:4
-
7贺岩松.乳腺癌组织中前列腺特异抗原检测的临床意义[J].临床军医杂志,2003,31(2):115-116.
-
8许杨,范振符,陈智周.前列腺特异性抗原及其临床应用[J].国外医学(放射医学核医学分册),2000,24(5):201-205. 被引量:11
-
9许海楠,高鹏,王军,孙丹.PSA及其相关指标与前列腺癌的诊断[J].医学综述,2010,16(12):1823-1825. 被引量:12
-
10姚尔固.多发性骨髓瘤临床研究进展[J].白血病.淋巴瘤,2002,11(4):230-232. 被引量:8